GeneDx Holdings Valuation
| WGSWW Stock | 0.22 0.03 15.79% |
GeneDx Holdings seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of GeneDx Holdings Corp from evaluating the firm fundamentals such as Return On Asset of -0.0827, number of shares shorted of 7.75 K, and Return On Equity of -0.36 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that GeneDx Holdings' price fluctuation is out of control at this time. Calculation of the real value of GeneDx Holdings Corp is based on 3 months time horizon. Increasing GeneDx Holdings' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the GeneDx stock is determined by what a typical buyer is willing to pay for full or partial control of GeneDx Holdings Corp. Since GeneDx Holdings is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GeneDx Stock. However, GeneDx Holdings' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.22 | Real 0.17 | Hype 0.23 | Naive 0.17 |
The intrinsic value of GeneDx Holdings' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence GeneDx Holdings' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of GeneDx Holdings Corp helps investors to forecast how GeneDx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GeneDx Holdings more accurately as focusing exclusively on GeneDx Holdings' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use GeneDx Holdings' intrinsic value based on its ongoing forecasts of GeneDx Holdings' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against GeneDx Holdings' closest peers.
GeneDx Holdings Cash |
|
GeneDx Valuation Trend
Analysing the historical paterns of GeneDx Holdings' enterprise value and its market capitalization is a good way to estimate and gauge the value of GeneDx Holdings Corp over time and is usually enough for investors to make rational market timing decisions.
GeneDx Holdings Total Value Analysis
GeneDx Holdings Corp is at this time anticipated to have takeover price of 0 with market capitalization of 0, debt of 119.77 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the GeneDx Holdings fundamentals before making investing decisions based on enterprise value of the companyGeneDx Holdings Investor Information
The company had not issued any dividends in recent years. Based on the key indicators related to GeneDx Holdings' liquidity, profitability, solvency, and operating efficiency, GeneDx Holdings Corp is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March.GeneDx Holdings Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. GeneDx Holdings has an asset utilization ratio of 42.76 percent. This indicates that the Company is making USD0.43 for each dollar of assets. An increasing asset utilization means that GeneDx Holdings Corp is more efficient with each dollar of assets it utilizes for everyday operations.GeneDx Holdings Profitability Analysis
The company reported the revenue of 202.57 M. Net Loss for the year was (175.77 M) with profit before overhead, payroll, taxes, and interest of 162.63 M.About GeneDx Holdings Valuation
Our relative valuation model uses a comparative analysis of GeneDx Holdings. We calculate exposure to GeneDx Holdings's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of GeneDx Holdings's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 54.6 M | 57.3 M | |
| Pretax Profit Margin | (1.00) | (1.05) | |
| Operating Profit Margin | (0.93) | (0.98) | |
| Net Loss | (1.00) | (1.05) | |
| Gross Profit Margin | 0.34 | 0.36 |
GeneDx Holdings Growth Indicators
Investing in growth stocks can be very risky. If the company such as GeneDx Holdings does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 24.3 M | |
| Shares Float | 18.8 M |
GeneDx Holdings Current Valuation Indicators
Valuation refers to the process of determining the present value of GeneDx Holdings Corp and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value GeneDx we look at many different elements of the entity such as GeneDx's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as GeneDx Holdings, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use GeneDx Holdings' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes GeneDx Holdings' worth.Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.